Book cover for Microbiology with Diseases by Body System

Microbiology with Diseases by Body System

Robert W. Bauman

ISBN #9780134477206

5th Edition

356 Questions

Group icon
21,994 Students Helped

Homework Questions

Right arrow
Summary
Learning Objectives
Key Concepts
Example Problems
Explanations
Common Mistakes

Summary

This chapter section focuses on the inhibition of cell wall synthesis as a strategy to control microbial growth. It explains how beta-lactams and bacitracin target bacterial cell walls by inhibiting enzymes responsible for peptidoglycan cross-linking, and how echinocandins disrupt fungal cell walls by interfering with beta-glucan synthesis. Central to these mechanisms is the principle of selective toxicity, which allows these drugs to target microbial cells specifically without adverse effects on human cells.

Learning Objectives

1

Understand the mechanisms by which antimicrobial drugs inhibit microbial cell wall synthesis.

2

Explain how beta-lactams and bacitracin disrupt bacterial cell wall synthesis through inhibition of cross-linking enzymes.

3

Describe the role of echinocandins in compromising fungal cell wall integrity by disrupting glucan polymer synthesis.

4

Recognize the principle of selective toxicity that allows antimicrobial drugs to target microbial cells without harming human cells.

Key Concepts

CONCEPT

DEFINITION

Antimicrobial Drugs

Medications that target and destroy or inhibit the growth of microorganisms such as bacteria and fungi.

Beta-lactams

A class of antibiotics that inhibit bacterial cell wall synthesis by binding to and inactivating enzymes responsible for cross-linking peptidoglycan.

Bacitracin

An antibiotic that interferes with the synthesis of bacterial cell walls by inhibiting the enzymes involved in peptidoglycan cross-linking.

Echinocandins

A class of antifungal drugs that disrupt the synthesis of beta-glucans, crucial components of fungal cell walls.

Peptidoglycan

A polymer consisting of sugars and amino acids that forms a mesh-like layer outside the bacterial plasma membrane, providing structural strength.

Selective Toxicity

A principle where drugs are designed to target microbial cells specifically without causing significant harm to host (human) cells.

Example Problems

Example 1

Diffusion and dilution tests that expose pathogens to antimicrobials are designed to determine _______. a. the spectrum of action of a drug b. which drug is most effective against a particular pathogen c. the amount of a drug to use against a particular pathogen d. both b and c

Example 2

In a Kirby-Bauer susceptibility test, the presence of a zone of inhibition around disks containing antimicrobial agents indicates _______. a. that the microbe does not grow in the presence of the agents b. that the microbe grows well in the presence of the agents c. the smallest amount of the agent that will inhibit the growth of the microbe d. the minimum amount of an agent that kills the microbe in question

Example 3

The key to successful chemotherapy is _______. a. selective toxicity b. a diffusion test c. the minimum inhibitory concentration test d. the spectrum of action

Example 4

Which of the following statements is relevant in explaining why sulfonamides are effective? a. Sulfonamides attach to sterol lipids in the pathogen, disrupt the membranes, and lyse the cells. b. Sulfonamides prevent the incorporation of amino acids into polypeptide chains. c. Humans and microbes use PABA differently in their metabolism. d. Sulfonamides inhibit DNA replication in both pathogens and human cells.

Example 5

Cross resistance is _______. a. the deactivation of an antimicrobial agent by a bacterial enzyme b. alteration of the resistant cells so that an antimicrobial agent cannot attach c. the mutation of genes that affect the cytoplasmic membrane channels so that antimicrobial agents cannot cross into the cell's interior d. resistance to one antimicrobial agent because of its similarity to another antimicrobial agent
Scroll left
Scroll right

Step-by-Step Explanations

QUESTION

How do beta-lactam antibiotics lead to bacterial cell death?

STEP-BY-STEP ANSWER:

Step 1: Beta-lactam antibiotics bind to penicillin-binding proteins (PBPs), which are enzymes critical for the cross-linking of peptidoglycan in the bacterial cell wall.
Step 2: By binding to these enzymes, the antibiotics inhibit their activity.
Step 3: The inhibition prevents the proper cross-linking of the peptidoglycan strands, leading to a weakened cell wall structure.
Step 4: The compromised cell wall cannot maintain its integrity under osmotic pressure, eventually leading to cell lysis and bacterial death.
Final Answer: Beta-lactams cause bacterial cell death by disrupting the cross-linking of peptidoglycan, weakening the cell wall and resulting in cell lysis.

Beta-lactam Antibiotics

QUESTION

How do echinocandins affect fungal cells?

STEP-BY-STEP ANSWER:

Step 1: Echinocandins target and inhibit the synthesis of beta-glucans, which are essential components of the fungal cell wall.
Step 2: Without sufficient beta-glucan production, the structural framework of the fungal cell wall is compromised.
Step 3: The weakened cell wall becomes less effective at protecting the cell, leading to increased susceptibility to osmotic stress.
Step 4: Ultimately, the disruption results in impaired cell integrity and fungal cell death.
Final Answer: Echinocandins weaken fungal cell walls by inhibiting beta-glucan synthesis, thereby compromising cell integrity and leading to cell death.

Echinocandins

Scroll left
Scroll right

Common Mistakes

  • Confusing the targets of antimicrobial drugs by assuming they affect human cells similarly to microbial cells.
  • Overlooking the specific biochemical differences between bacterial and fungal cell wall synthesis processes.
  • Misidentifying the role of beta-lactams as directly destroying cells rather than inhibiting key enzymes involved in cell wall synthesis.
  • Assuming that all antimicrobial drugs operate through the same mechanism, ignoring the unique actions of bacitracin and echinocandins.